首页> 美国卫生研究院文献>other >Deviant lysosomal Ca2+ signalling in neurodegeneration. An introduction
【2h】

Deviant lysosomal Ca2+ signalling in neurodegeneration. An introduction

机译:神经变性中的溶酶体Ca2 +信号异常。一个介绍

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Lysosomes are key acidic Ca2+ stores. The principle Ca2+-permeable channels of the lysosome are TRP mucolipins (TRPMLs) and NAADP-regulated two-pore channels (TPCs). Recent studies, reviewed in this collection, have linked numerous neurodegenerative diseases to both gain and loss of function of TRPMLs/TPCs, as well as to defects in acidic Ca2+ store content. These diseases span rare lysosomal storage disorders such as Mucolipidosis Type IV and Niemann–Pick disease, type C, through to more common ones such as Alzheimer and Parkinson disease. Cellular phenotypes, underpinned by endo-lysosomal trafficking defects, are reversed by chemical or molecular targeting of TRPMLs and TPCs. Lysosomal Ca2+ channels therefore emerge as potential druggable targets in combatting neurodegeneration.
机译:溶酶体是关键的酸性Ca 2 + 商店。溶酶体的Ca 2 + 渗透性主要通道是TRP粘蛋白(TRPML)和NAADP调节的两孔通道(TPC)。在该文献集中回顾的最新研究已将许多神经退行性疾病与TRPMLs / TPC功能的获得和丧失以及酸性Ca 2 + 存储内容的缺陷联系在一起。这些疾病涵盖了罕见的溶酶体贮积病,例如IV型粘膜血脂病和C型Niemann-Pick病,以及更常见的诸如Alzheimer和Parkinson病。以溶酶体运输缺陷为基础的细胞表型可通过化学或分子靶向TRPML和TPC逆转。因此,溶酶体Ca 2 + 通道成为对抗神经变性的潜在药物靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号